The MIP‐1α autocrine loop contributes to decreased sensitivity to anticancer drugs-Reference-Cited by-同舟云学术

The MIP‐1α autocrine loop contributes to decreased sensitivity to anticancer drugs

Published:2017-11-16 Issue:5 Volume:233 Page:4258-4271
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Tsubaki Masanobu¹,Takeda Tomoya¹,Tomonari Yoshika¹,Mashimo Kenji¹²,Koumoto Yu‐ichi¹,Hoshida Sachi¹,Itoh Tatsuki³,Imano Motohiro⁴,Satou Takao⁵,Sakaguchi Katsuhiko²,Nishida Shozo¹^ORCID

Affiliation:

1. Faculty of Pharmacy, Division of PharmacotherapyKindai UniversityKowakaeHigashi‐OsakaJapan

2. Department of PharmacyJapanese Red Cross Society Wakayama Medical CenterWakayamaJapan

3. Faculty of Agriculture, Department of Food Science and NutritionKindai UniversityNara, NaraJapan

4. Faculty of Medicine, Department of SurgeryKindai UniversityOsakasayama, OsakaJapan

5. Faculty of MedicineDepartment of PathologyKindai UniversityOsakasayama, OsakaJapan

Funder

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.26245

Reference52 articles.

1. Role for macrophage inflammatory protein (MIP)‐1alpha and MIP‐1beta in the development of osteolytic lesions in multiple myeloma;Abe M.;Blood,2002

2. The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy

3. Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma

4. Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells

5. Tumour cell survival signalling by the ERK1/2 pathway

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines;Leukemia Research;2024-04

2. Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM);Cell Communication and Signaling;2024-03-12

3. Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells;Cell Proliferation;2023-02-27

4. Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells;BMB Reports;2023-01-31

5. Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells;Clinical and Experimental Medicine;2022-11-30